Pinned
Join us in welcoming John C. Byrd, MD — our new director advancing discovery, improving cancer care, and changing lives @UPMC @PittTweet @PittHealthSci
UPMC Hillman Cancer Center
2,745 posts
UPMC Hillman Cancer Center
@UPMCHillmanCC
NCI-designated Comprehensive Cancer Center and a global leader in cancer research and cancer care affiliated with @PittTweet
- Sincere thanks to @Pitt_MBB Coach Jeff Capel (@jeffcapel) & wife, Kanika for their generous & much appreciated lunch for every single staff member @UPMCHillmanCC. Shout out to Food for Thought Deli, too! @UPMC @PittTweet
- Congratulations to Dr. Heath Skinner (@HSkinnerMDPhD) appointed professor & chair, Department of Radiation Oncology at @PittHealthSci & @UPMCHillmanCC.
- Jason J. Luke, MD, FACP, has been announced as the Interim Associate Director for Clinical Research at UPMC Hillman Cancer Center beginning February 1. Congratulations Dr. Luke! hillmanresearch.upmc.edu/announcing-jas…
- Please join us in welcoming Benjamin A. Nacev, MD, PhD, to UPMC Hillman Cancer Center. Dr. Nacev will lead a basic and translational laboratory focused on epigenetic dysregulation in sarcomas. @BenNacev @PittHealthSci
00:00- We're excited to welcome Dr. Taofeek Owonikoko (@teekayowo) to Hillman and @PittDeptofMed this July as Division Chief of Hem/Onc, and Hillman's associate director for translational research and co-leader of the Cancer Therapeutics Program. Learn more: hillmanresearch.upmc.edu/upmc-hillman-c…
- We are pleased to announce Patricia Opresko, PhD, as the Dr. Bernard F. Fisher Chair for Breast Cancer Discovery Science, a newly formed chair this year. Dr. Opresko's work focuses on how telomeres protect the genome to prevent cancer and premature aging. hillmanresearch.upmc.edu/patricia-opres…
- To our @UPMCHillmanCC physicians, nurses, staff, and all others working tirelessly to combat the spread of #COVID19, you are our heroes. Thank you for your dedication to the patients and communities you serve.
- Congratulations to Dr. Jason Luke for receiving an Ascending Star Award for his work in immunotherapy! “It's not an exaggeration to say that immuno-oncology has been a modern revolution in cancer treatment," says Dr. Luke. "The future of cancer treatment is immuno-oncology.”
- Benjamin A. Nacev, MD, PhD, has been named a Damon Runyon Clinical Investigator by the @DamonRunyon Cancer Research Foundation. Dr. Nacev will use this opportunity to continue his work on recurring genetic changes that happen in sarcoma patients. bit.ly/3KcSqyT
- We are pleased to announced the appointment of Jason Luke, MD, FACP (@jasonlukemd) to direct the newly established Cancer Immunotherapeutics Center & serve as associate professor of medicine at the University of Pittsburgh School of Medicine. upmc.com/media/news/051…
